118th Congress · HOUSE BILLBILL

H.R. 124 — Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

“To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.”

Health

Introduced Jan 9, 2023

Last action Jan 20, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jan 9, 2023

Step 2

Referred

Jan 20, 2023

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Jan 20, 2023

Referred to the Subcommittee on Health.

Jan 9, 2023

Introduced in House

Jan 9, 2023

Referred to the House Committee on Energy and Commerce.